[Detection of antibodies against pasteurella multocoida toxin with a cell culture method and an enzyme immunoassay] [Article in German]
Main Article Content
Abstract
Pasteurella multocida toxoid is the most important antigen in vaccines against progressive atrophic rhinitis in pigs. Testing antibodies against Pasteurella multocida toxin in a cell culture neutralisation assay on embryonic bovine lung cells and a modified, commercially available enzyme-linked immunosorbent assay (DAKO, Denmark) is sensitive and gives good reproducible results. Determination of antitoxin antibodies in swine and guinea pigs simultaneously in both methods resulted in good coefficients of correlation (r = 0.88 and 0.93). Induction of antibodies to Pasteurella multocida toxin by thirty batches of ten toxoid containing vaccines was tested by subcutaneous application of one fifth pigdose (0.4-1 ml) twice in intervals of three weeks. The animals showed neither signs of illness nor significant local or systemic reactions. Three weeks after the second immunisation 25 batches induced titres being at least 2 log2 dilutions higher than a parallel titrated reference serum (mean titre of reference serum was 1:23.26). Five batches belonging to one vaccine induced no detectable antibodies to the toxin. Additional testing of two negative and one positive batch of this vaccine in the target species by immunising them twice according to the manufacturers scheme, gave identical results. Therefore it is concluded that immunisation of guinea pigs and determination of humoral immune response in vitro, is a potent and ethical justifiable method to judge the quality of the Pasteurella multocida toxoid component of vaccines against progressive atrophic rhinitis in pigs.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Articles are distributed under the terms of the Creative Commons Attribution 4.0 International license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is appropriately cited (CC-BY). Copyright on any article in ALTEX is retained by the author(s).